H-Index
79
Scimago Lab
powered by Scopus
JCR
Clarivate
Analytics
16%
Acceptance
Rate
call: +1.631.470.9640
Mon-Fri 10 am - 2 pm EST

Logo

Medical Science Monitor Basic Research
AmJCaseRep

Annals
ISI-Home

eISSN: 1643-3750

Modulating gut microbiota as an anti-diabetic mechanism of berberine

Junling Han, Huiling Lin, Weiping Huang

Med Sci Monit 2011; 17(7): RA164-167

DOI: 10.12659/MSM.881842

Available online: 2011-06-21

Published: 2011-06-21


Berberine, one of the main constituents of a Chinese traditional herb used to treat bacterial diarrhea, has an effect of lowering glucose, which has been recently confirmed by many studies. However, the mechanism of berberine’s antidiabetic effect has not yet been well explained. Recent evidence suggests that the gut microbiota composition is associated with obesity and type 2 diabetes, which are closely associated with a low-grade inflammatory state. The protective effect against diabetes of gut microbiota modulation with probiotics or antibiotics has been confirmed in recent observations. Berberine has significant antimicrobial activity against several microbes through inhibiting the assembly function of FtsZ and halting the bacteria cell division. Because berberine acts topically in the gastrointestinal tract and it is poorly absorbed, berberine might modulate gut microbiota without systemic anti-infective activity. Our hypothesis is that gut microbiota modulation may be one mechanism of the antidiabetic effect of berberine. Our hypothesis may provide a novel explanation for berberine’s therapeutic effect in patients with diabetes mellitus.

Keywords: Medicine, Chinese Traditional, Hypoglycemic Agents - therapeutic use, Gene Expression Regulation - drug effects, Gastrointestinal Tract - microbiology, Diabetes Mellitus, Type 2 - microbiology, Blood Glucose - metabolism, Berberine - therapeutic use, Animals, Obesity - microbiology



Back